FDA: Only 76,837 adverse events after administration of 75 M COVID-19 vaccine doses
NO FEAR – A teenager from Baguio receives her COVID-19 vaccine during the ceremonial rollout of the city’s adolescent vaccination program on Oct. 29. —EV ESPIRITU
MANILA, Philippines — The Food and Drug Administration (FDA) has recorded only 76,837 adverse events following immunization (AEFI) or 0.1 percent of more than 75 million vaccinations against COVID-19.
“So far, our suspected adverse events are less than 0.1 percent of total doses administered, but we’ve had reports of 76,000, and a majority of them are very mild. Only 0.005 percent (3,874) are serious adverse reactions,” FDA Director General Eric Domingo said in a webinar, citing government data as of November 21.
“In our country, the most common things that are reported are an increase in blood pressure, especially before and right after vaccination. Of course, patients tend to be anxious on the day of vaccination. A fever would be the second one, headaches, pain on the area of vaccination, panghihina (fatigue), some get chills, muscle pain, cough, dizziness, and tiredness. These are the most common adverse events that we see,” Domingo said.
Despite these AEFI reports, Domingo stressed that all vaccines in the national immunization program are safe and effective.
He added that the majority of events thought to be related to the administration of a vaccine are “actually not due to the vaccine itself” and that many are “simply coincidental events.”
gsg
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
